ATE258442T1 - Matrixprotein zusammensetzungen für pfropfung in nicht mineralisierten geweben - Google Patents

Matrixprotein zusammensetzungen für pfropfung in nicht mineralisierten geweben

Info

Publication number
ATE258442T1
ATE258442T1 AT00906554T AT00906554T ATE258442T1 AT E258442 T1 ATE258442 T1 AT E258442T1 AT 00906554 T AT00906554 T AT 00906554T AT 00906554 T AT00906554 T AT 00906554T AT E258442 T1 ATE258442 T1 AT E258442T1
Authority
AT
Austria
Prior art keywords
grafting
matrix protein
protein compositions
mineralized tissues
enamel matrix
Prior art date
Application number
AT00906554T
Other languages
English (en)
Inventor
St Le Petter Lyngstadaas
Stina Gestrelius
Original Assignee
Biora Bioex Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biora Bioex Ab filed Critical Biora Bioex Ab
Application granted granted Critical
Publication of ATE258442T1 publication Critical patent/ATE258442T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Graft Or Block Polymers (AREA)
  • Materials For Medical Uses (AREA)
AT00906554T 1999-03-10 2000-03-09 Matrixprotein zusammensetzungen für pfropfung in nicht mineralisierten geweben ATE258442T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900337 1999-03-10
PCT/IB2000/000247 WO2000053197A1 (en) 1999-03-10 2000-03-09 Matrix protein compositions for grafting

Publications (1)

Publication Number Publication Date
ATE258442T1 true ATE258442T1 (de) 2004-02-15

Family

ID=8092401

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00906554T ATE258442T1 (de) 1999-03-10 2000-03-09 Matrixprotein zusammensetzungen für pfropfung in nicht mineralisierten geweben

Country Status (8)

Country Link
EP (1) EP1165102B1 (de)
JP (1) JP4726300B2 (de)
AT (1) ATE258442T1 (de)
AU (1) AU2821200A (de)
DE (1) DE60007973T2 (de)
DK (1) DK1165102T3 (de)
ES (1) ES2215028T3 (de)
WO (1) WO2000053197A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001274374A1 (en) * 2000-06-20 2002-01-02 Biora Ab Matrix protein compositions for dentin regeneration
DE60222633T2 (de) * 2001-02-23 2008-06-19 Institut Straumann Ag Verwendung von matrixprotein für gesteuerte geweberegenerationen
US7033611B2 (en) 2001-02-23 2006-04-25 Biora Bioex Ab Matrix protein compositions for guided connective tissue growth
JP2004307454A (ja) * 2003-02-21 2004-11-04 Seikagaku Kogyo Co Ltd 生理活性ペプチド及びこれを含有する薬剤
JP5069125B2 (ja) 2004-12-10 2012-11-07 シュトラウマン・ホールディング・アクチェンゲゼルシャフト 新規なタンパク質配合物
EP2496273B1 (de) 2009-11-02 2016-11-30 Straumann Holding AG Gereinigte emd-proteinzusammensetzung
WO2011073447A1 (en) 2009-12-18 2011-06-23 Straumann Holding Ag Emd c-depleted
US9789190B2 (en) 2010-10-15 2017-10-17 Straumann Holding Ag EMD formulation comprising PGA
US9957314B2 (en) 2011-05-09 2018-05-01 Hadasit Medical Research Services And Development Ltd. Regeneration and repair of mesenchymal tissue using amelogenin
WO2015106970A1 (en) * 2014-01-17 2015-07-23 Straumann Holding Ag Process for producing emd of increased stability

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672032A (en) * 1983-11-09 1987-06-09 University Of Southern California Dental enamel production
SE454480B (sv) * 1986-09-25 1988-05-09 Lars Hammarstrom Bindningsinducerande komposition
SE461313B (sv) * 1988-03-17 1990-02-05 Biora Ab Bindningsinducerande komposition

Also Published As

Publication number Publication date
ES2215028T3 (es) 2004-10-01
EP1165102B1 (de) 2004-01-28
WO2000053197A1 (en) 2000-09-14
JP2002538212A (ja) 2002-11-12
EP1165102A1 (de) 2002-01-02
AU2821200A (en) 2000-09-28
DE60007973D1 (de) 2004-03-04
DK1165102T3 (da) 2004-06-01
JP4726300B2 (ja) 2011-07-20
DE60007973T2 (de) 2004-12-23

Similar Documents

Publication Publication Date Title
TR200201440T2 (tr) Biomedikal kullanım için radyum-223 hazırlanması
EP1196444B8 (de) Exendin-4 konjugate und ihre medizinische verwendung
DE60038922D1 (de) Zusammensetzungen für den wiederaufbau von knochengewebe
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
AR020055A1 (es) Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma.
TR200000927T2 (tr) Prostaglandin agonistleri ve kemik bozukluklarının tedavisi
DE60045394D1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
WO2003064449A3 (en) Bioactive keratin peptides
AU3692001A (en) Compositions and methods for enhancing drug delivery across biological membranesand tissues
NO20022599D0 (no) Klorofyll- og bakterioklorofyllesteres, deres fremstilling og farmasöytiske sammensetninger som innbefatter slike
FR2721198B1 (fr) Prothèse implantable souple, utilisée en chirurgie pour l'augmentation de volume ou la reconstruction des tissus mous, notamment prothèse mammaire.
TR200001977T2 (tr) Lipofilik glukokortikosteroit içeren miseller ihtiva eden bileşimler
ATE271886T1 (de) Hyaluronsäure enthaltende zusammensetzungen zur abgabe osteogener proteine
PT749317E (pt) Aplicacoes terapeuticas de produtos dimericos de proteinas bactericidas indutoras da permeabilidade
TR200100054T2 (tr) Paroksetin metansülfonat
ATE426397T1 (de) Copolymer-zusammensetzungen zur oralen verabreichung
NO20031159D0 (no) Melkesyrebakterier som er i stand til å redusere et individs tendens til åutvikle allergiske reaksjoner
WO2001038303A3 (fr) Analogues de la vitamine d
ATE258442T1 (de) Matrixprotein zusammensetzungen für pfropfung in nicht mineralisierten geweben
DK1007566T3 (da) Terapeutisk anvendelse af SMR1-protein og aktive derivater deraf
ATE220918T1 (de) Matrixprotein enthaltende zusammensetzungen zur wundheilung
EA200300532A1 (ru) Способ и состав для связывания ацетальдегида в слюне, желудке и толстой кишке
DK0482097T3 (da) Tensidpræparater og fremgangsmåder
AU9363398A (en) Hepatitis c receptor protein cd81
AU2001274374A1 (en) Matrix protein compositions for dentin regeneration

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1165102

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee